Journey Medical Corporation (DERM) vs Sofgen Pharma S.A (PROCF)
- Journey Medical Corporation DERM 4.97 −3.12%
- Sofgen Pharma S.A PROCF 0.03 0.00%
Journey Medical Corporation and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation is the larger, with a market value of $144.7M against $114.0M — 1.3× the size. Journey Medical Corporation has negative trailing earnings, so its P/E is not meaningful; Sofgen Pharma S.A trades at 0.1×. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against 5.10%. Sofgen Pharma S.A has the higher net margin (9.52% vs −8.95%) and the higher return on invested capital (15.2% vs −5.89%). Across the 18 metrics below, Sofgen Pharma S.A leads on 12 and Journey Medical Corporation on 6.
Valuation
Profitability
| Metric | DERM | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.45% | 56.16% | 53.94% |
| Operating margin | (4.41%) | 17.01% | 0.00% |
| Net margin | (8.95%) | 9.52% | 0.00% |
| Free cash flow margin | (10.99%) | 17.66% | 0.00% |
| Return on equity | (23.77%) | (213.06%) | (0.40%) |
| Return on assets | (6.80%) | 8.82% | (3.32%) |
| Return on invested capital | (5.89%) | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack